VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 5 filers reported holding VERTEX PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $7,283,000 | -61.9% | 486 | -61.3% | 0.66% | -46.9% |
| Q3 2017 | $19,111,000 | +82.9% | 1,257 | +55.0% | 1.25% | +82.6% |
| Q2 2017 | $10,451,000 | +76.3% | 811 | +49.6% | 0.68% | +113.8% |
| Q1 2017 | $5,927,000 | +171.8% | 542 | +83.1% | 0.32% | +152.0% |
| Q4 2016 | $2,181,000 | -3.8% | 296 | +13.8% | 0.13% | +49.4% |
| Q3 2016 | $2,267,000 | +1.3% | 260 | 0.0% | 0.08% | -27.4% |
| Q2 2016 | $2,237,000 | +753.8% | 260 | +687.9% | 0.12% | +800.0% |
| Q1 2016 | $262,000 | -99.8% | 33 | -99.7% | 0.01% | -99.6% |
| Q4 2014 | $113,953,000 | +5.8% | 9,592 | 0.0% | 3.60% | -13.0% |
| Q3 2014 | $107,728,000 | +14.2% | 9,592 | -3.8% | 4.14% | +2.2% |
| Q2 2014 | $94,358,000 | +125.1% | 9,966 | +68.2% | 4.05% | +72.2% |
| Q1 2014 | $41,909,000 | -42.3% | 5,926 | -39.3% | 2.35% | -49.2% |
| Q4 2013 | $72,576,000 | +46.1% | 9,768 | +49.1% | 4.63% | +43.3% |
| Q3 2013 | $49,670,000 | +18.3% | 6,551 | +24.6% | 3.23% | +15.2% |
| Q2 2013 | $41,988,000 | – | 5,257 | – | 2.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMC-Chicago, LLC | 47,200 | $14,871,304 | 0.02% |
| SIMPLEX TRADING, LLC | 62,100 | $19,565 | 0.02% |
| GROUP ONE TRADING, L.P. | 14,300 | $4,505,501 | 0.02% |
| JANE STREET GROUP, LLC | 55,200 | $17,391,864 | 0.01% |
| Allianz Asset Management GmbH | 11,200 | $3,528,784 | 0.01% |
| SG Americas Securities, LLC | 11,000 | $130 | 0.00% |
| JPMORGAN CHASE & CO | 23,200 | $7,310,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |